Network-pharmacology-based validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis.

MLA

Wang, Neng, et al. “Network-Pharmacology-Based Validation of TAMS/CXCL-1 as Key Mediator of XIAOPI Formula Preventing Breast Cancer Development and Metastasis.” Scientific Reports, vol. 7, no. 1, Nov. 2017, p. 14513. EBSCOhost, https://doi.org/10.1038/s41598-017-15030-3.

APA

Wang, N., Zheng, Y., Gu, J., Cai, Y., Wang, S., Zhang, F., Chen, J., Situ, H., Lin, Y., & Wang, Z. (2017). Network-pharmacology-based validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis. Scientific Reports, 7(1), 14513. https://doi.org/10.1038/s41598-017-15030-3

Chicago

Wang, Neng, Yifeng Zheng, Jiangyong Gu, Youli Cai, Shengqi Wang, Fengxue Zhang, Jianping Chen, Honglin Situ, Yi Lin, and Zhiyu Wang. 2017. “Network-Pharmacology-Based Validation of TAMS/CXCL-1 as Key Mediator of XIAOPI Formula Preventing Breast Cancer Development and Metastasis.” Scientific Reports 7 (1): 14513. doi:10.1038/s41598-017-15030-3.